Increased WDR26 expression in samples of malignant cancers at the protein level was verified immunohistochemically by comparing breast cancer tissues (stage II and III) to matched, adjacent, normal breast tissues (Figure 2A). This evidence concerns the gene WDR26 and breast carcinoma.